J. Rauh

VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer

T. Decker, C. Lerchenmüller, A. Muendlein, 2019, Breast Cancer Research and Treatment.

Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL

N. Harbeck, E. Stickeler, T. Decker, 2023, Breast Cancer Research and Treatment.